Literature DB >> 8292026

Occurrence of specific sterols in Pneumocystis carinii.

M Florin-Christensen1, J Florin-Christensen, Y P Wu, L Zhou, A Gupta, H Rudney, E S Kaneshiro.   

Abstract

We have examined the sterol composition and biosynthesis of rat Pneumocystis carinii. We found a number of lipid components among the nonsaponifiable fraction that appear unique to P. carinii. These lipids are present in P. carinii purified preparations and P. carinii-infected whole lungs but absent from control lungs. They show chromatographic properties typical of sterols on GC and HPLC; they are present in free and esterified sterol fractions isolated by thin layer chromatography, they are precipitated by digitonin and they are labeled upon incubation of purified P. carinii cell suspensions with [3H] mevalonate and [3H] squalene. The finding of these sterols opens new opportunities for the identification of chemotherapeutic targets against P. carinii.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8292026     DOI: 10.1006/bbrc.1994.1033

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

Review 1.  Analysis of current antifungal agents and their targets within the Pneumocystis carinii genome.

Authors:  Aleksey Porollo; Jaroslaw Meller; Yogesh Joshi; Vikash Jaiswal; A George Smulian; Melanie T Cushion
Journal:  Curr Drug Targets       Date:  2012-11       Impact factor: 3.465

2.  Heterogeneity of Pneumocystis sterol profiles of samples from different sites in the same pair of lungs suggests coinfection by distinct organism populations.

Authors:  Z Amit; E S Kaneshiro
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

3.  Characterizations of neutral lipid fatty acids and cis-9,10-epoxy octadecanoic acid in Pneumocystis carinii carinii.

Authors:  E S Kaneshiro; J E Ellis; Z Guo; K Jayasimhulu; J N Maiorano; K A Kallam
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

4.  Sterols of Pneumocystis carinii hominis organisms isolated from human lungs.

Authors:  E S Kaneshiro; Z Amit; J Chandra; R P Baughman; C Contini; B Lundgren
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

5.  Inhibitors of delta24(25) sterol methyltransferase block sterol synthesis and cell proliferation in Pneumocystis carinii.

Authors:  J A Urbina; G Visbal; L M Contreras; G McLaughlin; R Docampo
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

Review 6.  The lipids of Pneumocystis carinii.

Authors:  E S Kaneshiro
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

7.  Inhibitors of sterol biosynthesis and amphotericin B reduce the viability of pneumocystis carinii f. sp. carinii.

Authors:  E S Kaneshiro; M S Collins; M T Cushion
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

8.  Phospholipid composition of Pneumocystis carinii carinii and effects of methylprednisolone immunosuppression on rat lung lipids.

Authors:  Z Guo; E S Kaneshiro
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

9.  Pneumocysterol [(24Z)-ethylidenelanost-8-en-3beta-ol], a rare sterol detected in the opportunistic pathogen Pneumocystis carinii hominis: structural identity and chemical synthesis.

Authors:  E S Kaneshiro; Z Amit; M M Swonger; G P Kreishman; E E Brooks; M Kreishman; K Jayasimhulu; E J Parish; H Sun; S A Kizito; D H Beach
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-05       Impact factor: 11.205

10.  Functional characterization and localization of Pneumocystis carinii lanosterol synthase.

Authors:  Tiffany M Joffrion; Margaret S Collins; Thomas Sesterhenn; Melanie T Cushion
Journal:  Eukaryot Cell       Date:  2009-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.